✦ LIBER ✦

Analysis of patent applications relating to peroxisome proliferator-activated receptor (PPAR) ligands in 2004

✍ Scribed by Miyachi, Hiroyuki

Book ID: 111887020
Publisher: Informa plc
Year: 2005
Tongue: English
Weight: 200 KB
Volume: 15
Category: Article
ISSN: 1354-3776
DOI: 10.1517/13543776.15.11.1521

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erratum to: Sex dimorphic actions of ros

Erratum to: Sex dimorphic actions of rosiglitazone in generalised peroxisome proliferator-activated receptor-γ (PPAR-γ)-deficient mice

✍ S. Z. Duan; M. G. Usher; E. L. Foley; D. S. Milstone; F. C. Brosius; R. M. Morte 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 109 KB

Distribution of peroxisome proliferator-

Distribution of peroxisome proliferator-activated receptors (PPARs) in human skeletal muscle and adipose tissue: relation to insulin action

✍ Loviscach, M.; Rehman, N.; Carter, L.; Mudaliar, S.; Mohadeen, P.; Ciaraldi, T. 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 145 KB

0009 Peroxisome proliferator-activated r

0009 Peroxisome proliferator-activated receptor (PPAR)-gamma ligand enhances the growth inhibitory activity of tamoxifen in MCF-7 cells

✍ H. Youn; B. Lee; M. Park; J. Yoon; S. Jung 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Modulation of peroxisome proliferator-ac

Modulation of peroxisome proliferator-activated receptors (PPARs) by PPARα- and PPARγ-specific ligands and by 17β-estradiol in isolated zebrafish hepatocytes

✍ A. Ibabe; A. Herrero; M.P. Cajaraville 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 486 KB

Approaches to understanding the importan

Approaches to understanding the importance and clinical implications of peroxisome proliferator-activated receptor gamma (PPARγ) signaling in prostate cancer

✍ Ming Jiang; Scott B. Shappell; Simon W. Hayward 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 385 KB 👁 2 views

## Abstract The development and maintenance of the prostate are dependent upon a complex series of interactions occurring between the epithelial and stromal tissues (Hayward and Cunha [2000]: Radiol. Clin. N. Am. 38:1–14). During the process of prostatic carcinogenesis, there are progressive change

Peroxisome proliferator-activated recept

Peroxisome proliferator-activated receptor (PPAR)-γ ligand inhibits the progression of pancreatic fibrosis in vivo and profibrogenic action in pancreatic myofibroblast

✍ Kyoko Shimizu; Shoko Hisada; Keiko Shiratori; Makio Kobayashi; Naoaki Hayashi 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 193 KB